Researchers tested the effects of a daily multivitamin on cognitive changes in a study of 573 participants with in-person visits in the COSMOS trial. The researchers also conducted a meta-analysis among over 5,000 non-overlapping participants across the three separate cognition studies within the COSMOS trial. Results showed a statistically significant benefit for cognition among participants taking the multi-vitamin compared to placebo, suggesting that a multi-vitamin could help prevent memory loss and slow cognitive aging among older adults.
Read more …Third major study finds evidence that daily multivitamin supplements improve memory and slow...
Glaucoma is the leading cause of irreversible blindness around the globe, affecting up to 44 million people. Although people of African ancestry are most frequently and severely affected by this hereditary disease, its genetic underpinnings in this population have rarely been studied. Now, a team of investigators has published findings revealing previously unknown inherited genetic variants that contribute to primary open-angle glaucoma (POAG), the most common form of the disease.
Read more …Study with over 11,000 individuals of African descent finds genetic variants linked to glaucoma
An exhalation delivery system that uses a patient's own breath to carry the anti-inflammatory compound fluticasone (EDS-FLU) directly to the sinuses reduced chronic sinus infection (sinusitis) symptoms and decreased aggravations and infections associated with chronic inflammation of the sinus by more than 50 percent, researchers reported.
Read more …'Exhalation' system improves symptoms for most common form of chronic sinus infections